Study of Screening Brain MRIs in Stage IV Breast Cancer

Part of paid clinical trials in Clearwater, Florida.

Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Study ID
NCT05115474
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Magnetic Resonance Imaging — DIAGNOSTIC_TEST
    Participants will undergo MRI imaging with and without contrast.

Study Details

The study is a single arm, nonrandomized phase II prospective study, with the goal of investigating the role of screening brain MRIs in neurologically asymptomatic patients with metastatic breast cancer.

Key Dates

Start date
Dec 21, 2021
Status verified
May 2026
Primary completion
Jun 16, 2026
Completion
Oct 31, 2026

Study Design

Enrollment
170 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING

Arms

  • Experimental: Screening MRI
    Participants will undergo a screening brain MRI. Patients will undergo a second brain MRI at first systemic progression or at 6 months whichever event occurs sooner.

Primary Outcome Measure

Rate of Brain Metastasis [ Time Frame: at Baseline ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Morton Plant Mease- BaycareClearwaterFlorida33756
Ronica H. Nanda, MD
[email protected]
Ronica H. Nanda, MD (PRINCIPAL_INVESTIGATOR)
Moffitt Cancer CenterTampaFlorida33612-

Find similar trials in Clearwater, FL

By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
Morton Plant Mease- Baycare· Clearwater, FLMoffitt Cancer Center· Tampa, FL

Related Studies